Asserter profile

Neurent Medical Limited

operating company0 patents now4 ever1 cases filed during tenure2 connections

Also seen as: NEURENT MEDICAL LIMITED · Neurent Medical Ltd

PTAB exposure

4of this entity’s patents have been challenged at PTAB (4 total proceedings).

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nneurent_medical["Neurent Medical Limited"]
    Ntownley_david["TOWNLEY, David"]
    Nclaret_european_specialty_lending_iii_r_l["CLARET EUROPEAN SPECIALTY LENDING COMPA…"]
    Ntownley_david -->|"2024 · Assignment · 11998262"| Nneurent_medical
    Nneurent_medical -->|"2024 · Security Interest · 11998262"| Nclaret_european_specialty_lending_iii_r_l
    Nneurent_medical -->|"2024 · Security Interest · 12089889"| Nclaret_european_specialty_lending_iii_r_l
    Ntownley_david ==>|"⚖️ 2024 · ASSIGNMENT · 12096973"| Nneurent_medical
    Nneurent_medical -->|"2024 · SECURITY INTEREST · 12096973"| Nclaret_european_specialty_lending_iii_r_l
    Ntownley_david -->|"2024 · Assignment of Assignors Interest · 12096974"| Nneurent_medical
    Nneurent_medical -->|"2024 · Security Interest · 12096974"| Nclaret_european_specialty_lending_iii_r_l
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nneurent_medical focal
    class Nclaret_european_specialty_lending_iii_r_l operating

Patents previously held (4)

Connected entities (2)

Correspondent attorneys (4)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.